Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02371317
Other study ID # KentSU
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date May 1, 2015
Est. completion date May 31, 2020

Study information

Verified date August 2019
Source Kent State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research study is to examine the efficacy of two stress management interventions in reducing blood pressure (BP) in patients who have prehypertension (BP between 120/80 and 139/89). It is expected that participants will be better able to control their BP through reducing stress and increasing healthy lifestyle behaviors.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 141
Est. completion date May 31, 2020
Est. primary completion date May 31, 2019
Accepts healthy volunteers No
Gender All
Age group 21 Years to 70 Years
Eligibility Inclusion Criteria:

- Unmedicated high blood pressure (SBP of 120-139 or DBP of 80-89)

- BMI in the range of 19-40

- Interest in attempting to control blood pressure through lifestyle modification

Exclusion Criteria:

- pacemakers

- uncontrolled hypertension (SBP=140 or DBP=90)

- atrial fibrillation

- myocardial infarction (MI)

- percutaneous transluminal coronary angioplasty (PTCA)

- coronary artery bypass graft (CABG) within 6 months of enrollment

- congestive heart failure

- uncorrected primary valvular disease hypertrophic or restrictive cardiomyopathy

- uncorrected thyroid heart disease

- chronic kidney disease

- persistent tachyarrhythmia

- JNC risk category C (target organ damage, diabetes)

- patients who are pregnant or plan to become pregnant within 9 months

- patients who are lactating

- patients unable to comply with assessment procedures

- patients with alcohol or drug abuse within 12 months

- patients who consume more than 21 alcoholic drinks per week

- patients who are current smokers

- patients who are unable to provide informed consent or who have dementia

- patients with previous extensive meditation or yoga training

- patients with blood pressure =140/90

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mindfulness-Based Stress Reduction
Patients are randomized to an intervention
Stress Management Education
Patients are randomized to an intervention
Other:
American Heart Association Recommended Self-Care
All Patients receive AHA Recommended Self-Care

Locations

Country Name City State
United States W.O. Walker Building Cleveland Ohio
United States University of Pennsylvania Perelman School of Medicine Philadelphia Pennsylvania

Sponsors (3)

Lead Sponsor Collaborator
Kent State University Case Western Reserve University, University of Pennsylvania

Country where clinical trial is conducted

United States, 

References & Publications (1)

Hughes JW, Fresco DM, Myerscough R, van Dulmen MH, Carlson LE, Josephson R. Randomized controlled trial of mindfulness-based stress reduction for prehypertension. Psychosom Med. 2013 Oct;75(8):721-8. doi: 10.1097/PSY.0b013e3182a3e4e5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Systolic Clinic Blood Pressure All clinic blood pressure assessments will be completed in a quiet, climate controlled room according to American Heart Association guidelines. The mean of the three seated readings on the non- dominant arm will be averaged to define clinic blood pressure. Week 0, Week 4, Week 8, Week 34, and Week 60
Primary Change in Diastolic Clinic Blood Pressure All clinic blood pressure assessments will be completed in a quiet, climate controlled room according to American Heart Association guidelines. The mean of the three seated readings on the non- dominant arm will be averaged to define clinic blood pressure. Week 0, Week 4, Week 8, Week 34, and Week 60
Secondary Change in 24-hour Ambulatory Systolic Blood Pressure Participants will complete 24-hour Ambulatory Blood Pressure Monitoring with the Oscar 2 oscillometric blood pressure monitor. The Oscar will be programmed to take three blood pressure measurements per hour from 6 AM till 11 PM and two BP measurements per hour from 11 PM to 6 AM. During each reading, participants will be instructed to drop their arms to their sides as soon as they sense the cuff inflating, and to keep it relaxed and still until a few seconds after the deflation has finished. Ambulatory SBP and DBP will be derived by computing the mean of all valid readings obtained during waking hours and nighttime sleep. Week 0, Week 8, Week 60
Secondary Change in 24-hour Ambulatory Diastolic Blood Pressure Participants will complete 24-hour Ambulatory Blood Pressure Monitoring with the Oscar 2 oscillometric blood pressure monitor. The Oscar will be programmed to take three blood pressure measurements per hour from 6 AM till 11 PM and two BP measurements per hour from 11 PM to 6 AM. During each reading, participants will be instructed to drop their arms to their sides as soon as they sense the cuff inflating, and to keep it relaxed and still until a few seconds after the deflation has finished. Ambulatory SBP and DBP will be derived by computing the mean of all valid readings obtained during waking hours and nighttime sleep. Week 0, Week 8, Week 60
See also
  Status Clinical Trial Phase
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Completed NCT02551640 - Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients N/A
Recruiting NCT01483430 - Effect of Ginseol Kg1 on Blood Pressure Lowering Phase 3
Completed NCT01637909 - Korean Life-Style Modification Effects on Blood Pressure N/A
Terminated NCT01295216 - Use of Mobile Technology to Prevent Progression of Pre-hypertension in Latin American Urban Settings N/A
Unknown status NCT01308983 - Study of Amiloride on Vascular Phenotypes in Young Adults With Prehypertension Phase 4
Active, not recruiting NCT03596099 - Rice Vinegar as an Intervention to Lower Blood Pressure in Adults With Prehypertension and 10-year CVD Risk <10% N/A
Completed NCT04326686 - Measuring Individual Responses to a Wholegrains and Nuts Intervention to Reduce Blood Pressure in Prehypertension N/A
Completed NCT03898518 - The Effects of a Jump Rope Exercise Program on Body Composition and Self-efficacy in Obese Adolescent Girls N/A
Terminated NCT01983462 - Vascular Dysfunction in Human Obesity Hypertension Phase 2
Completed NCT01458496 - Health Coaching to Effect Lifestyle Behaviour Change N/A
Completed NCT01472692 - Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure Phase 4
Completed NCT03266510 - Inspiratory Muscle Strength Training to Improve Blood Pressure and Physiological Function N/A
Completed NCT02998840 - A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure Phase 2
Completed NCT01974570 - Effect and Safety of Marealis RPC (Refined Peptide Concentrate) in Mild or Moderate Hypertensive Subjects Phase 2
Completed NCT02326766 - Blood Pressure Lowering Effect of Supplementation With Korea Red Ginseng Associated With Reductions in Circulating Lp-PLA2 Activity and Lysophospatidylcholines and an Increase in Dihydrobiopterin in Prehypertensive Subjects Phase 3
Completed NCT01395329 - Nebivolol and the Endothelin (ET)-1 System Phase 4
Completed NCT01331486 - Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract Phase 1
Completed NCT05274971 - Diet and Exercise on Ambulatory Blood Pressure N/A
Completed NCT03006471 - Effect of Dapagliflozin on Blood Pressure Variability in Prediabetes and Prehypertension Phase 4